We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

99 hedge funds and large institutions have $48.4M invested in Inovio Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,155% more call options, than puts

Call options by funds: $2.5M | Put options by funds: $111K

134% more capital invested

Capital invested by funds: $20.7M → $48.4M (+$27.8M)

11.25% more ownership

Funds ownership: 27.73% → 38.97% (+11%)

4% less funds holding

Funds holding: 103 → 99 (-4)

14% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 28

19% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 27

Holders
99
Holders Change
-4
Holders Change %
-3.88%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
22
Reduced
27
Closed
28
Calls
$2.5M
Puts
$111K
Net Calls
+$2.39M
Net Calls Change
+$1.09M

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.56M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.25M
3
BCM
Boxer Capital Management
California
+$4.4M
4
Millennium Management
Millennium Management
New York
+$3.11M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$4.03M
2
Bank of America
Bank of America
North Carolina
-$1.21M
3
CSS
Cubist Systematic Strategies
Connecticut
-$349K
4
Citadel Advisors
Citadel Advisors
Florida
-$300K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$192K
Name Holding Trade Value Shares
Change 		Change in
Stake
TWC
76
TD Waterhouse Canada
Ontario, Canada
$97 -$10 -5 -11%
National Bank of Canada
77
National Bank of Canada
Quebec, Canada
$96 -$25 -13 -24%
1NWS
78
1 North Wealth Services
Maryland
$96 – – –
SWP
79
Strategic Wealth Partners
Ohio
$68 – – –
Optiver Holding
80
Optiver Holding
Netherlands
$56 +$46 +24 New
AP
81
Atwood & Palmer
Missouri
$43 – – –
GLF
82
Groupe la Francaise
France
$42 +$38 +20 New
CA
83
CoreCap Advisors
Michigan
$37 – – –
FFA
84
Farther Finance Advisors
California
$37 – – –
WANY
85
Wealthspire Advisors (New York)
New York
$36 +$29 +15 New
CIBC Private Wealth Group
86
CIBC Private Wealth Group
Georgia
$33 -$153K -79,986 -100%
IA
87
IFP Advisors
Florida
$33 – – –
KFI
88
Key Financial Inc
Pennsylvania
$33 – – –
TIM
89
Thompson Investment Management
Wisconsin
$30 – – –
GSWM
90
Golden State Wealth Management
California
$23 – – –
NSIM
91
North Star Investment Management
Illinois
$16 – – –
AFG
92
Albion Financial Group
Utah
$12 – – –
JFGIW
93
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$10 -$8 -4 -50%
GWSG
94
GPS Wealth Strategies Group
Colorado
$9 – – –
HI
95
Harbour Investments
Wisconsin
$7 +$6 +3 New
Barclays
96
Barclays
United Kingdom
$2 -$155 -81 -99%
Northwestern Mutual Wealth Management
97
Northwestern Mutual Wealth Management
Wisconsin
$2 -$71 -37 -97%
AUB
98
Atlantic Union Bankshares
Virginia
$2 +$2 +1 New
DTC
99
Deep Track Capital
Connecticut
– -$4.03M -1,981,370 Closed
CSS
100
Cubist Systematic Strategies
Connecticut
– -$349K -171,561 Closed
2 3
4
5 6

INO Hedge Fund Activity: Q3 2025 in Review

99 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2025, worth a combined $48.4M — up 134% from $20.7M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of INO and 24 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 22 added.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $6.56M. The largest seller was Deep Track Capital, exiting entirely with an estimated $4.03M sold.

  • 99 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2025, down from 103 in Q2 2025.
  • Funds reported $48.4M of Inovio Pharmaceuticals stock for Q3 2025, up 134% quarter-over-quarter.
  • 24 funds opened new Inovio Pharmaceuticals positions in Q3 2025 and 28 closed out, a net change of -4 holders.
  • The largest Inovio Pharmaceuticals buyer in Q3 2025 was Adage Capital Partners, an estimated $6.56M added.
  • The largest Inovio Pharmaceuticals seller in Q3 2025 was Deep Track Capital, an estimated $4.03M sold.

Based on aggregated 13F filings for Q3 2025.